RT Journal Article
SR Electronic
T1 Visualizing the COVID-19 pandemic in Bangladesh using coxcombs: A tribute to Florence Nightingale
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.23.20110866
DO 10.1101/2020.05.23.20110866
A1 Khan, Hasinur Rahaman
A1 Howlader, Tamanna
YR 2020
UL http://medrxiv.org/content/early/2020/05/24/2020.05.23.20110866.abstract
AB Following detection of the first confirmed case of COVID-19 in early December 2019 in Wuhan, China, nearly six months have passed and almost every country in the world is battling against the COVID-19 war. The frontline warriors, namely the doctors, nurses and healthcare staff, have in many countries struggled to care for the sick under conditions of limited resources and protection and the threat of an overwhelmed healthcare system. It is during times such as this, that we draw strength and inspiration from Florence Nightingale - a passionate statistician, social reformer, feminist champion and a pioneer of modern nursing and data visualization. Nightingale’s famed Florence Night-ingle Diagram also known as “coxcomb”, which was created 150 years ago and used to display the causes of death in the British Army hospital barracks, demonstrated how data visualization techniques could be a powerful medium of communication and a force for change. This paper pays tribute to Nightingale’s work by using data from Bangladesh to show that the coxcomb graph is still relevant in the era of COVID-19. The coxcomb graphs that have been produced to display COVID-19 data have provided deeper insights into the trends and relative changes of variables over the course of the pandemic. The paper also describes codes that allow one to easily reproduce the graphs using the statistical programming language R.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThe study was based on secondary dataFunding StatementThere is no funding for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study used secondary data and hence no IRB approval is necessaryAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe working data set used for this study has been submitted to the journal as additional supporting file.